Toward the treatment for Alzheimer’s disease: adsorption is primary mechanism of removing amyloid β protein with hollow-fiber dialyzers of the suitable materials, polysulfone and polymethyl methacrylate

A potential therapeutic system for Alzheimer’s disease using adsorbents with alkyl ligands for removal of blood amyloid β

(2012) Kazunori Kawaguchi et al.   JOURNAL OF ARTIFICIAL ORGANS

Potential therapeutic system for Alzheimer’s disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients

(2012) Masao Kato et al.   JOURNAL OF NEURAL TRANSMISSION

Reduction of Alzheimer’s Disease Amyloid-β in Plasma by Hemodialysis and Its Relation to Cognitive Functions

(2011) N. Kitaguchi et al.   BLOOD PURIFICATION

Novel therapeutic approach for Alzheimer’s disease by removing amyloid β protein from the brain with an extracorporeal removal system

(2010) Kazunori Kawaguchi et al.   JOURNAL OF ARTIFICIAL ORGANS

Decreased Clearance of CNS  -Amyloid in Alzheimer's Disease

(2010) K. G. Mawuenyega et al.   SCIENCE

Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for abeta mobilization

(2009) M. Boada et al.   DRUG NEWS & PERSPECTIVES

Amyloid-  Peptide (A ) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: A  Dimers and Trimers Correlate with Neurotoxicity

(2008) L. W. Hung et al.   JOURNAL OF NEUROSCIENCE

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

(2008) O. L. Lopez et al.   NEUROLOGY